Literature DB >> 31272909

Vitamin D, linoleic acid, arachidonic acid and COX-2 in colorectal cancer patients in relation to disease stage, tumour localisation and disease progression.

Berska Joanna1, Bugajska Jolanta2, Grabowska Agnieszka3, Hodorowicz-Zaniewska Diana4, Sztefko Krystyna2.   

Abstract

BACKGROUND AND STUDY AIMS: Evidence shows that vitamin D and cyclooxygenase type 2 (COX-2) might play role in aetiology/progression of cancer. It is suggested that antitumour effect of vitamin D depends on vitamin D-receptor (VDR) expression. Aim of the study was to determine vitamin D and polyunsaturated fatty acids in colorectal cancer patients. PATIENTS AND METHODS: A total of 39 patients with colorectal cancer (mean ± SD age: 65.5 ± 6.8 years) and 25 controls (mean ± SD age: 51.0 ± 6.9 years) were studied. 25-hydroxycholecalciferol-25(OH)D3 in serum was quantitatively determined by high-performance liquid chromatography (HPLC). Levels of linoleic acid (LA) and arachidonic acid (AA) of serum phospholipids were measured by gas-chromatography (GC). Expression of VDR and COX-2 in normal colonic mucosa and tumour tissue was measured by real time polymerase chain reaction (RT-PCR).
RESULTS: The mean value of 25(OH)D3 was significantly lower in the colorectal cancer patients with early stages of the disease and in patients with tumour confined to the rectum compared to control group (p < 0.02, p < 0.03, respectively). The higher concentration of AA (patients with early stages of the disease) and lower concentration of LA (patients with the advanced stages of the disease) was noticed compared to the control group. For the patients with the early stages of the disease the higher mean fold change of mRNA VDR and the lower mean fold change of mRNA COX-2 was noticed (p < 0.03, p < 0.02, respectively).
CONCLUSION: The assessment of vitamin D status in patients with colorectal cancer should include measurement of mRNA VDR expression in tumour tissue.
Copyright © 2019 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arachidonic acid; COX-2; Colorectal cancer; Linoleic acid; Vitamin D

Mesh:

Substances:

Year:  2019        PMID: 31272909     DOI: 10.1016/j.ajg.2019.05.007

Source DB:  PubMed          Journal:  Arab J Gastroenterol        ISSN: 1687-1979            Impact factor:   2.076


  4 in total

1.  Effects of Cyclooxygenase-2 Inhibitors on Gastrointestinal Malignancies: a Systematic Review and Meta-analysis.

Authors:  Yuan-Xi Jiang; Ying Chen; Hui-Hui Sun; Shu-Chang Xu
Journal:  Indian J Surg Oncol       Date:  2022-05-10

2.  Preparation, COX-2 Inhibition and Anticancer Activity of Sclerotiorin Derivatives.

Authors:  Tao Chen; Yun Huang; Junxian Hong; Xikang Wei; Fang Zeng; Jialin Li; Geting Ye; Jie Yuan; Yuhua Long
Journal:  Mar Drugs       Date:  2020-12-29       Impact factor: 5.118

Review 3.  Interactions of Colorectal Cancer, Dietary Fats, and Polymorphisms of Arachidonate Lipoxygenase and Cyclooxygenase Genes: A Literature Review.

Authors:  Maryam Gholamalizadeh; Nazanin Majidi; Shirin Tajaddod; Sepideh Abdollahi; Seyed Mohammad Poorhosseini; Mina Ahmadzadeh; Mohammad Naimi Joubani; Samaneh Mirzaei Dahka; Hanieh Shafaei; Mogge Hajiesmaeil; Atiyeh Alizadeh; Saeid Doaei; Anahita Houshiar-Rad
Journal:  Front Oncol       Date:  2022-07-19       Impact factor: 5.738

4.  Vitamin D receptor knockdown attenuates the antiproliferative, pro‑apoptotic and anti‑invasive effect of vitamin D by activating the Wnt/β‑catenin signaling pathway in papillary thyroid cancer.

Authors:  Rui Pang; Ye Xu; Xiaonan Hu; Bo Liu; Jiawei Yu
Journal:  Mol Med Rep       Date:  2020-09-17       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.